These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12604666)

  • 1. Serine 329 of the mu-opioid receptor interacts differently with agonists.
    Pil J; Tytgat J
    J Pharmacol Exp Ther; 2003 Mar; 304(3):924-30. PubMed ID: 12604666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the hydrophilic Asn230 residue of the mu-opioid receptor in the potency of various opioid agonists.
    Pil J; Tytgat J
    Br J Pharmacol; 2001 Oct; 134(3):496-506. PubMed ID: 11588103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of p-fluorofentanyl on cloned human opioid receptors and exploration of the role of Trp-318 and His-319 in mu-opioid receptor selectivity.
    Ulens C; Van Boven M; Daenens P; Tytgat J
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1024-33. PubMed ID: 10945855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and electrophysiological characterization of cyclic morphiceptin analogues.
    Pil J; Van der Veken P; Bal G; Augustyns K; Haemers A; Tytgat J
    Biochem Pharmacol; 2004 May; 67(10):1887-95. PubMed ID: 15130765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of clozapine on the delta- and kappa-opioid receptors and the G-protein-activated K+ (GIRK) channel expressed in Xenopus oocytes.
    Kobayashi T; Ikeda K; Kumanishi T
    Br J Pharmacol; 1998 Feb; 123(3):421-6. PubMed ID: 9504382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sugar solution analgesia: the effects of glucose on expressed mu opioid receptors.
    Kracke GR; Uthoff KA; Tobias JD
    Anesth Analg; 2005 Jul; 101(1):64-8, table of contents. PubMed ID: 15976207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation of the mu-opioid receptor regulates agonist intrinsic efficacy.
    McLaughlin JP; Chavkin C
    Mol Pharmacol; 2001 Jun; 59(6):1360-8. PubMed ID: 11353794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interferon-alpha on cloned opioid receptors expressed in Xenopus oocytes.
    Kobayashi T; Washiyama K; Ikeda K
    Life Sci; 2004 Dec; 76(4):407-15. PubMed ID: 15530503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
    Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G
    Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain.
    Chaipatikul V; Loh HH; Law PY
    J Pharmacol Exp Ther; 2003 Jun; 305(3):909-18. PubMed ID: 12626655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol opens G-protein-activated inwardly rectifying K+ channels.
    Kobayashi T; Ikeda K; Kojima H; Niki H; Yano R; Yoshioka T; Kumanishi T
    Nat Neurosci; 1999 Dec; 2(12):1091-7. PubMed ID: 10570486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Funaltrexamine, a gauge for the recognition site of wildtype and mutant H297Q mu-opioid receptors.
    Spivak CE; Beglan CL; Zöllner C; Surratt CK
    Synapse; 2003 Jul; 49(1):55-60. PubMed ID: 12710015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies.
    Ulens C; Baker L; Ratka A; Waumans D; Tytgat J
    Biochem Pharmacol; 2001 Nov; 62(9):1273-82. PubMed ID: 11705461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid receptors from a lower vertebrate (Catostomus commersoni): sequence, pharmacology, coupling to a G-protein-gated inward-rectifying potassium channel (GIRK1), and evolution.
    Darlison MG; Greten FR; Harvey RJ; Kreienkamp HJ; Stühmer T; Zwiers H; Lederis K; Richter D
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8214-9. PubMed ID: 9223341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
    Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Threonine 180 is required for G-protein-coupled receptor kinase 3- and beta-arrestin 2-mediated desensitization of the mu-opioid receptor in Xenopus oocytes.
    Celver JP; Lowe J; Kovoor A; Gurevich VV; Chavkin C
    J Biol Chem; 2001 Feb; 276(7):4894-900. PubMed ID: 11060299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The weaver mutation changes the ion selectivity of the affected inwardly rectifying potassium channel GIRK2.
    Tong Y; Wei J; Zhang S; Strong JA; Dlouhy SR; Hodes ME; Ghetti B; Yu L
    FEBS Lett; 1996 Jul; 390(1):63-8. PubMed ID: 8706831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dual modulation of GIRK1/GIRK2 channels by opioid receptor ligands.
    Ulens C; Daenens P; Tytgat J
    Eur J Pharmacol; 1999 Dec; 385(2-3):239-45. PubMed ID: 10607882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in GIRK1/GIRK2 deactivation kinetics and basal activity in the presence and absence of RGS4.
    Ulens C; Daenens P; Tytgat J
    Life Sci; 2000 Sep; 67(19):2305-17. PubMed ID: 11065178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained inhibition of neurotransmitter release from nontransient receptor potential vanilloid type 1-expressing primary afferents by mu-opioid receptor activation-enkephalin in the spinal cord.
    Zhou HY; Chen SR; Chen H; Pan HL
    J Pharmacol Exp Ther; 2008 Nov; 327(2):375-82. PubMed ID: 18669865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.